Stephen G. Walsh

Array ( [id] => 3656965 [patent_doc_number] => 05627047 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Astrocyte-specific transcription of human genes' [patent_app_type] => 1 [patent_app_number] => 8/197463 [patent_app_country] => US [patent_app_date] => 1994-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 8060 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627047.pdf [firstpage_image] =>[orig_patent_app_number] => 197463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3446785 [patent_doc_number] => 05420228 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-05-30 [patent_title] => 'Fluorescent-labelled bleomycin analogues' [patent_app_type] => 1 [patent_app_number] => 8/182862 [patent_app_country] => US [patent_app_date] => 1994-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 8804 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/420/05420228.pdf [firstpage_image] =>[orig_patent_app_number] => 182862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3620765 [patent_doc_number] => 05593877 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Nucleic acid and recombinant production of vespid venom hyaluronidase' [patent_app_type] => 1 [patent_app_number] => 8/180209 [patent_app_country] => US [patent_app_date] => 1994-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 21028 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593877.pdf [firstpage_image] =>[orig_patent_app_number] => 180209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3583097 [patent_doc_number] => 05552144 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Immunogenic shiga-like toxin II variant mutants' [patent_app_type] => 1 [patent_app_number] => 8/180761 [patent_app_country] => US [patent_app_date] => 1994-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 7023 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552144.pdf [firstpage_image] =>[orig_patent_app_number] => 180761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3554062 [patent_doc_number] => 05543303 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-06 [patent_title] => 'Recombinant myelomonocytic differentiation antigen CD14' [patent_app_type] => 1 [patent_app_number] => 8/165583 [patent_app_country] => US [patent_app_date] => 1993-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3879 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/543/05543303.pdf [firstpage_image] =>[orig_patent_app_number] => 165583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3566212 [patent_doc_number] => 05484711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-16 [patent_title] => 'DNA sequences, recombinant DNA molecules and processes for producing lipocortins III, IV, V & VI' [patent_app_type] => 1 [patent_app_number] => 8/162641 [patent_app_country] => US [patent_app_date] => 1993-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 8906 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/484/05484711.pdf [firstpage_image] =>[orig_patent_app_number] => 162641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3117466 [patent_doc_number] => 05449759 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-09-12 [patent_title] => 'Hemoglobins with intersubunit desulfide bonds' [patent_app_type] => 1 [patent_app_number] => 8/158483 [patent_app_country] => US [patent_app_date] => 1993-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 17380 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/449/05449759.pdf [firstpage_image] =>[orig_patent_app_number] => 158483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3484450 [patent_doc_number] => 05474769 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-12 [patent_title] => 'Treatment of microbial infection by monocyte stimulation with interleukin-7' [patent_app_type] => 1 [patent_app_number] => 8/152950 [patent_app_country] => US [patent_app_date] => 1993-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 8931 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/474/05474769.pdf [firstpage_image] =>[orig_patent_app_number] => 152950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3486721 [patent_doc_number] => 05474921 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-12 [patent_title] => 'Expression and purification of phosphoinositide-specific phospholipase C-.gamma.' [patent_app_type] => 1 [patent_app_number] => 8/138641 [patent_app_country] => US [patent_app_date] => 1993-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5314 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/474/05474921.pdf [firstpage_image] =>[orig_patent_app_number] => 138641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695001 [patent_doc_number] => 05595884 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Papillomavirus E2 transactivation repressor proteins and DNA' [patent_app_type] => 1 [patent_app_number] => 8/094128 [patent_app_country] => US [patent_app_date] => 1993-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 20606 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/595/05595884.pdf [firstpage_image] =>[orig_patent_app_number] => 094128 [rel_patent_id] =>[rel_patent_doc_number] =>)